Genenta Science S.p.A.
GNTA
$4.25
$0.07721.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.32M | 1.36M | 1.33M | 1.35M | 1.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.80M | 2.88M | 2.43M | 2.45M | 2.66M |
| Operating Income | -2.80M | -2.88M | -2.43M | -2.45M | -2.66M |
| Income Before Tax | -2.60M | -2.68M | -2.17M | -2.19M | -2.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.60M | -2.68M | -2.17M | -2.19M | -2.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.60M | -2.68M | -2.17M | -2.19M | -2.63M |
| EBIT | -2.80M | -2.88M | -2.43M | -2.45M | -2.66M |
| EBITDA | -2.78M | -2.87M | -2.42M | -2.44M | -2.64M |
| EPS Basic | -0.14 | -0.15 | -0.12 | -0.12 | -0.14 |
| Normalized Basic EPS | -0.09 | -0.09 | -0.07 | -0.08 | -0.09 |
| EPS Diluted | -0.14 | -0.15 | -0.12 | -0.12 | -0.14 |
| Normalized Diluted EPS | -0.09 | -0.09 | -0.07 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 18.29M | 18.29M | 18.26M | 18.26M | 18.22M |
| Average Diluted Shares Outstanding | 18.29M | 18.29M | 18.26M | 18.26M | 18.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |